Central Medical Supply

Central Medical Supply

Central Medical Supply manages capital deployed into the durable medical equipment (DME) and home healthcare supply chain. The firm's mandate centers on distributing respiratory therapy devices, mobility aids, and wound-care products directly to patients, long-term care facilities, and home health agencies. The strategy focuses on reimbursement-driven cash flows. Operating businesses within the portfolio derive revenue primarily from Medicare, Medicaid, and private insurer reimbursements. The investment posture targets regional consolidations, acquiring fragmented DME providers and integrating their back-office billing, inventory management, and logistics operations. The geographic footprint concentrates on the continental United States, with an operational emphasis on states maintaining favorable certificate-of-need and competitive-bidding waivers. The firm's scale and team size remain undisclosed in available public record. Organizational filings indicate no publicly listed adjacent philanthropic foundations, operating companies outside the core DME vertical, or disclosed club memberships tied to the principal. Structurally, the firm differs from a generic family office by functioning as a direct operating company aggregator rather than a passive limited partner. Its architecture embeds billing-compliance expertise and Medicare regulatory knowledge into the investment function, making the regulatory cycle itself a driver of deal origination and value creation.